Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijrobp.2020.07.026 http://scihub22266oqcxt.onion/10.1016/j.ijrobp.2020.07.026 32707264!7373065!32707264     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Radiat+Oncol+Biol+Phys 2020 ; 108 (5): 1134-1139 Nephropedia Template TP {{tp|p=32707264|t=2020. Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results |pdf=|usr=}}{{32707264}} gab.com Text Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results JO: Int J Radiat Oncol Biol Phys http://www.kidney.de/pget.php?&tw=1&pmid=32707264 #FOAvip PURPOSE: The COVID-19 outbreak is affecting people worldwide. Many infected patients have respiratory involvement that may progress to acute respiratory distress syndrome. This pilot study aimed to evaluate the clinical efficacy of low-dose whole-lung radiation therapy in patients with COVID-19 pneumonia. METHODS AND MATERIALS: In this clinical trial, conducted in Iran, we enrolled patients with COVID-19 who were older than 60 years and hospitalized to receive supplementary oxygen for their documented pneumonia. Participants were treated with whole-lung irradiation in a single fraction of 0.5 Gy plus the national protocol for the management of COVID-19. Vital signs (including blood oxygenation and body temperature) and laboratory findings (interleukin-6 and C-reactive peptide) were recorded before and after irradiation. RESULTS: Between May 21, 2020 and June 24, 2020, 5 patients received whole-lung irradiation. They were followed for 5 to 7 days to evaluate the response to treatment and toxicities. The clinical and paraclinical findings of 4 of the 5 patients (patient 4 worsened and died on day 3) improved on the first day of irradiation. Patient 3 opted out of the trial on the third day after irradiation. The mean time to discharge was 6 days for the other 3 patients. No acute radiation-induced toxicity was recorded. CONCLUSIONS: With a response rate of 80%, whole-lung irradiation in a single fraction of 0.5 Gy had encouraging results in oxygen-dependent patients with COVID-19 pneumonia. Twit Text FOAVip Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results ????Int J Radiat Oncol Biol Phys http://www.kidney.de/pget.php?&tw=1&pmid=32707264 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32707264 #FOAvip English Wikipedia <ref>{{Cite pmid|32707264}}</ref> Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results #MMPMID32707264 Ameri A; Rahnama N; Bozorgmehr R; Mokhtari M; Farahbakhsh M; Nabavi M; Shoaei SD; Izadi H; Yousefi Kashi AS; Dehbaneh HS; Taghizadeh-Hesary F Int J Radiat Oncol Biol Phys 2020[Dec]; 108 (5): 1134-1139 PMID32707264show ga PURPOSE: The COVID-19 outbreak is affecting people worldwide. Many infected patients have respiratory involvement that may progress to acute respiratory distress syndrome. This pilot study aimed to evaluate the clinical efficacy of low-dose whole-lung radiation therapy in patients with COVID-19 pneumonia. METHODS AND MATERIALS: In this clinical trial, conducted in Iran, we enrolled patients with COVID-19 who were older than 60 years and hospitalized to receive supplementary oxygen for their documented pneumonia. Participants were treated with whole-lung irradiation in a single fraction of 0.5 Gy plus the national protocol for the management of COVID-19. Vital signs (including blood oxygenation and body temperature) and laboratory findings (interleukin-6 and C-reactive peptide) were recorded before and after irradiation. RESULTS: Between May 21, 2020 and June 24, 2020, 5 patients received whole-lung irradiation. They were followed for 5 to 7 days to evaluate the response to treatment and toxicities. The clinical and paraclinical findings of 4 of the 5 patients (patient 4 worsened and died on day 3) improved on the first day of irradiation. Patient 3 opted out of the trial on the third day after irradiation. The mean time to discharge was 6 days for the other 3 patients. No acute radiation-induced toxicity was recorded. CONCLUSIONS: With a response rate of 80%, whole-lung irradiation in a single fraction of 0.5 Gy had encouraging results in oxygen-dependent patients with COVID-19 pneumonia. |*SARS-CoV-2[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19/*radiotherapy[MESH] |Female[MESH] |Humans[MESH] |Iran[MESH] |Lung/radiation effects[MESH] |Male[MESH] |Middle Aged[MESH] |Pilot Projects[MESH] |Radiotherapy Dosage[MESH]Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course R(epmc).pdf DeepDyve Pubget Overpricing